Aquestive Therapeutics Inc (AQST)

Cash & Equivalents

$98.49M

Quarterly · Period ending: · USD

AQST logo

AQST Cash & Equivalents

Latest reported$98.49M
AQST Quarterly Cash & Equivalents (-$9.21M → $98.49M)
High-resolution chart · PNG

AQST cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
98,490,000
110,734,000
121,169,000
129,062,999
60,536,000
68,657,000
71,546,000
77,893,000
89,870,000
95,200,000
23,872,000
24,917,000
22,436,000
26,882,000
27,273,000
18,649,000
17,695,000
14,736,000
28,024,000
31,164,000
34,234,000
27,498,000
31,807,000
17,064,000
25,422,000
35,521,000
49,326,000
20,914,000
22,165,000
39,934,000
60,599,000
63,982,000
10,638,000
16,488,000
17,379,000
-9,209,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.